GS vs VRTV: Which Is the Better Buy?

Side-by-side comparison of The Goldman Sachs Group, Inc. and Veritiv Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-25.
The Goldman Sachs Group, Inc. Β· Financial Services
$923.29
+25.9% upside to fair value
Med Conviction Grade C High Quality
VS
Veritiv Corporation Β· Industrials
$169.99
-45.0% upside to fair value
Med Conviction Grade D
QuantHub Verdict
GS has more upside to fair value (+25.9%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric GS VRTV
Current Price $923.29 $169.99
Fair Value Estimate $1,162.79 $93.49
Upside to Fair Value +25.9% -45.0%
Market Cap $272.4B $2.3B
Forward P/E β€” β€”
EV / EBITDA 26.3x 5.4x
Price / Sales 2.3x 0.4x
Price / FCF β€” 10.4x
Revenue Growth YoY +22.9% -19.0%
Gross Margin 57.3% 22.7%
Operating Margin 24.8% 5.9%
Return on Equity 17.0% 48.6%
Dividend Yield 1.95% 1.48%
FCF Yield β€” 9.57%
Analyst Consensus Hold Hold
Investment Thesis
GS β€” The Goldman Sachs Group, Inc.
Goldman Sachs is a global financial services firm operating four divisions: Investment Banking, Global Markets, Asset Management, and Consumer & Wealth Management, with 46,200 full-time employees and a market cap of $272.38 billion at a current price of $923.29. The business quality is high because of its leading franchise in advisory, underwriting, and trading, evidenced by a 17.0% ROE, a 57.3% …
VRTV β€” Veritiv Corporation
Veritiv Corporation is a business-to-business distributor of specialty packaging, facility solutions, print, and publishing products, operating through four segments with a network of distribution centers and roughly 5,000 employees. The business quality is mixed: it generates a strong 48.6% ROE and trades at a low 7.13 trailing P/E and 5.44 EV/EBITDA, but revenue declined 19.0% year over year in…
Accumulation Zones
Metric GS VRTV
Zone Low $872.09 $70.12
Zone High $988.37 $79.47
In Buy Zone? Yes No
← GS Research    VRTV Research β†’    All Research